Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01)
| קרן | US Food and Drug Administration (FDA) |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 27/02/2023 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The purpose of this grant is to encourage new approaches to support therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers.
Funding: $500,000 per year Duration: 5 years
Research Authority due date: 25.12.22 LOI (encouraged) due date: 3.1.23 Full proposal due date: 27.2.23 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 05/12/2022 |
